Helmet PET scanner may bolster brain injury evaluation in stroke patients | WHO: Dementia deaths more than doubled over 15 years | Study finds antibiotic intake prior to cancer immunotherapy reduces its efficacy
February 17, 2017
CONNECT WITH SNMMI LinkedInFacebookTwitterYoutube
SNMMI SmartBrief
News for nuclear medicine and molecular imaging professionals
SIGN UP ⋅   FORWARD
Top Story
Helmet PET scanner may bolster brain injury evaluation in stroke patients
West Virginia University researchers have developed a helmet PET scanner containing smaller detectors with crystal arrays that can detect the degree of brain injury caused by stroke within 30 seconds, reducing patients' risk of developing severe disabilities. The device, described at the American Association for the Advancement of Science meeting, also has the potential to improve sports concussion diagnoses and could be available for clinical use within two years, researchers said.
The Guardian (London) (2/16),  The Telegraph (London) (tiered subscription model) (2/16) 
LinkedIn Twitter Facebook Google+ Email
Clinical News & Research
WHO: Dementia deaths more than doubled over 15 years
Dementia led to 1.54 million deaths in 2015, more than doubling the total from 2000, according to the World Health Organization. The number is likely to keep growing because experimental drugs have not proven effective against dementia, WHO says.
Bloomberg (2/15) 
LinkedIn Twitter Facebook Google+ Email
Study finds antibiotic intake prior to cancer immunotherapy reduces its efficacy
Researchers from the Gustave Roussy Cancer Institute in France found that disease progression was more rapid among the 80 study patients with metastatic renal cell carcinoma who took antibiotics within a month before their scheduled cancer immunotherapy session compared with those who didn't. The findings were presented at a presscast prior to the Genitourinary Cancers Symposium being held in Florida.
Medscape (free registration) (2/13) 
LinkedIn Twitter Facebook Google+ Email
Treat back pain with drug-free options first, group says
The American College of Physicians issued new guidelines calling for people with low back pain to try drug-free treatments, such as physical therapy or heat wraps, before using medication. The report, published in the Annals of Internal Medicine, called for opioid use to be a last resort in cases of long-lasting pain and for people to start medication therapy with nonsteroidal anti-inflammatory drugs.
HealthDay News (2/13) 
LinkedIn Twitter Facebook Google+ Email
Industry Report
Axsome's antidepressant gets FDA fast-track status
Axsome Therapeutics has received fast-track designation from the FDA for its treatment-resistant depression drug candidate AXS-05. The firm is evaluating the safety and efficacy of the drug candidate in a late-stage trial and also plans to investigate it under a Phase II/III trial as a treatment for agitation associated with Alzheimer's disease.
eMPR.com (2/14) 
LinkedIn Twitter Facebook Google+ Email
CMC amendment filed to FDA by BriaCell for vaccine trial
A chemistry, manufacturing and control amendment has been filed by BriaCell Therapeutics to the FDA concerning a new batch of BriaVax -- a whole cell vaccine candidate indicated for patients with stage IV breast cancer -- and its BriaTest cell line testing platform. The firm plans to start Phase I/IIa trials for the vaccine candidate before the end of next month if the FDA accepts the amendment.
OutSourcing-Pharma.com (2/13) 
LinkedIn Twitter Facebook Google+ Email
News from the Field
Pa. health system opens after-hours cancer clinic
Pennsylvania's Allegheny Health Network has a cancer clinic, staffed by nurses trained in oncology, that is open after hours so cancer patients suffering side effects of treatment do not have long waits in the emergency department. Allegheny found in 2014 there were 3,000 ED visits by cancer patients across its system, with some wait times lasting hours.
Pittsburgh Tribune-Review (2/14) 
LinkedIn Twitter Facebook Google+ Email
Health Policy
Study: ACA repeal would hammer drug, mental health care
Repeal of the Affordable Care Act would cut $5.5 billion from drug abuse and mental health treatment, and could have serious implications for death rates, according to a new study. The loss would bring a 50% increase in Americans unable to access help for opioid dependence, researchers say.
The Charlotte Observer (N.C.)/McClatchy Washington Bureau (2/14) 
LinkedIn Twitter Facebook Google+ Email
Advancing Health Care
Remote monitoring use increases among patients, providers
Berg Insight reported a 44% boost in remote monitoring use among providers and patients in 2016, and the firm expects use to continue to increase at a compound annual growth rate of 47.9%, reaching 50.2 million by 2021. MHealth connectivity solutions and care delivery platforms "are two of the most rapidly developing parts of the mHealth technology value chain," Berg said.
mHealth Intelligence (2/13) 
LinkedIn Twitter Facebook Google+ Email
From SNMMI
SNMMI outreach tools help members reach out to referring physicians
SNMMI's Outreach Committee has created numerous resources to equip members in their efforts to educate referring physicians and other appropriate audiences in their communities. Visit the SNMMI Outreach Tools page to view a presentation on outreach strategies and find educational print and video materials suitable for sharing as part of your outreach efforts. The page is a work in progress; submit suggestions for additional materials to Linda Budzinski at lbudzinski@snmmi.org.
LinkedIn Twitter Facebook Google+ Email
Nuclear medicine technologists: Save 10% on these great study and reference tools
Save 10% on the Steves' Review of Nuclear Medicine Technology, 4th edition, and Practical Mathematics in Nuclear Medicine Technology, 2nd edition, when you purchase them together as part of the best-selling Technologist Study Combo. It's an in-depth review at a great price!
LinkedIn Twitter Facebook Google+ Email
Learn more about SNMMI:
SNMMI | News & Publications | Meetings | Education
Membership | Support Education/Research in Your Field
  
  
The important thing is this: to be able at any moment to sacrifice what we are for what we could become.
Charles Du Bos,
writer and critic
LinkedIn Twitter Facebook Google+ Email
  
  
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items above are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Meryl Harold
P: 202.407.7828
Editor  -  Tara Rosenzweig
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information